These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8686761)

  • 21. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paracrine-stimulated gene expression profile favors estradiol production in breast tumors.
    Amin SA; Huang CC; Reierstad S; Lin Z; Arbieva Z; Wiley E; Saborian H; Haynes B; Cotterill H; Dowsett M; Bulun SE
    Mol Cell Endocrinol; 2006 Jul; 253(1-2):44-55. PubMed ID: 16735089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of telomerase genes in thyroid carcinoma.
    Hoang-Vu C; Boltze C; Gimm O; Poremba C; Dockhorn-Dworniczak B; Köhrle J; Rath FW; Dralle H
    Int J Oncol; 2002 Aug; 21(2):265-72. PubMed ID: 12118320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interphase cytogenetic analysis of serous ovarian tumors of low malignant potential: comparison with serous cystadenomas and invasive serous carcinomas.
    Diebold J; Deisenhofer I; Baretton GB; Blasenbreu S; Suchy B; Schneiderbanger K; Meier W; Haas CJ; Löhrs U
    Lab Invest; 1996 Oct; 75(4):473-85. PubMed ID: 8874380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p16 overexpression: a potential early indicator of transformation in ovarian carcinoma.
    Shigemasa K; Hu C; West CM; Clarke J; Parham GP; Parmley TH; Korourian S; Baker VV; O'Brien TJ
    J Soc Gynecol Investig; 1997; 4(2):95-102. PubMed ID: 9101469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Telomerase activity and expression of human telomerase RNA component and human telomerase reverse transcriptase in lung carcinomas.
    Kumaki F; Kawai T; Hiroi S; Shinomiya N; Ozeki Y; Ferrans VJ; Torikata C
    Hum Pathol; 2001 Feb; 32(2):188-95. PubMed ID: 11230706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular genetic analysis of TGF-beta1 in ovarian neoplasia.
    Cardillo MR; Yap E; Castagna G
    J Exp Clin Cancer Res; 1997 Mar; 16(1):49-56. PubMed ID: 9148861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of gonadotrophin releasing hormone receptor I is a favorable prognostic factor in epithelial ovarian cancer.
    Wilkinson SJ; Kucukmetin A; Cross P; Darby S; Gnanapragasam VJ; Calvert AH; Robson CN; Edmondson RJ
    Hum Pathol; 2008 Aug; 39(8):1197-204. PubMed ID: 18495208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical detection of human telomerase reverse transcriptase (hTERT) and c-kit in serous ovarian carcinoma: a clinicopathologic study.
    Brustmann H
    Gynecol Oncol; 2005 Sep; 98(3):396-402. PubMed ID: 16005054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of gonadotropin and activin receptor messenger ribonucleic acid in human ovarian epithelial neoplasms.
    Minegishi T; Kameda T; Hirakawa T; Abe K; Tano M; Ibuki Y
    Clin Cancer Res; 2000 Jul; 6(7):2764-70. PubMed ID: 10914722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta.
    Zhou J; Gurates B; Yang S; Sebastian S; Bulun SE
    Cancer Res; 2001 Mar; 61(5):2328-34. PubMed ID: 11280806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Keratinocyte growth factor (KGF) induces aromatase activity in cultured MCF-7 human breast cancer cells.
    Zhang Y; Kulp SK; Sugimoto Y; Farrar WB; Brueggemeier RW; Lin YC
    Anticancer Res; 1998; 18(4A):2541-6. PubMed ID: 9703907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival.
    Davidson B; Hadar R; Stavnes HT; Trope' CG; Reich R
    Hum Pathol; 2009 May; 40(5):705-13. PubMed ID: 19157507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity.
    Bar JK; Grelewski P; Popiela A; Noga L; Rabczyñski J
    Gynecol Oncol; 2004 Oct; 95(1):23-31. PubMed ID: 15385106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of the ets-1 proto-oncogene in human colorectal carcinoma.
    Nakayama T; Ito M; Ohtsuru A; Naito S; Sekine I
    Mod Pathol; 2001 May; 14(5):415-22. PubMed ID: 11353051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In situ human telomerase reverse transcriptase expression pattern in normal and neoplastic ovarian tissues.
    Baykal A; Thompson JA; Xu XC; Hahn WC; Deavers MT; Malpica A; Gershenson DM; Silva EG; Liu J
    Oncol Rep; 2004 Feb; 11(2):297-302. PubMed ID: 14719058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alphav integrin expression is a novel marker of poor prognosis in advanced-stage ovarian carcinoma.
    Goldberg I; Davidson B; Reich R; Gotlieb WH; Ben-Baruch G; Bryne M; Berner A; Nesland JM; Kopolovic J
    Clin Cancer Res; 2001 Dec; 7(12):4073-9. PubMed ID: 11751504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative detection of alternatively spliced transcripts of the aromatase cytochrome P450 (CYP19) gene in aromatase-expressing human cells by competitive RT-PCR.
    Agarwal VR; Bulun SE; Simpson ER
    Mol Cell Probes; 1995 Dec; 9(6):453-64. PubMed ID: 8808317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel alpha-fetoprotein-V messenger RNA isoforms in humans.
    Tagaya H; Fukasawa H; Shoda T; Hoshi K; Hirata S
    Reprod Sci; 2009 Aug; 16(8):794-801. PubMed ID: 19494365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HMGA1 protein over-expression is a frequent feature of epithelial ovarian carcinomas.
    Masciullo V; Baldassarre G; Pentimalli F; Berlingieri MT; Boccia A; Chiappetta G; Palazzo J; Manfioletti G; Giancotti V; Viglietto G; Scambia G; Fusco A
    Carcinogenesis; 2003 Jul; 24(7):1191-8. PubMed ID: 12807722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.